Infleqtion Secures Three Major DOE Projects Under Genesis Mission
Craig-Hallum initiates coverage on Infleqtion with a Buy rating and $19 price target.
Already have an account? Sign in.
Craig-Hallum initiates coverage on Infleqtion with a Buy rating and $19 price target.
Tempest gets an exclusive option to license Senlang’s CD7-targeted lentiviral in-vivo CAR-T, now in Phase 1 for relapsed multiple myeloma.
Axon plans $1 billion of 0% convertible notes due 2031, plus a $150 million option.
Senators failed to reach 60 votes on the Clarity Act. All Democrats and four Republicans stopped debate on digital asset rules.